BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25185644)

  • 1. An update on the medical treatment of Graves' hyperthyroidism.
    Marinò M; Latrofa F; Menconi F; Chiovato L; Vitti P
    J Endocrinol Invest; 2014 Nov; 37(11):1041-8. PubMed ID: 25185644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-thionamide antithyroid drug options in Graves' hyperthyroidism.
    Ruslan A; Okosieme OE
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):67-79. PubMed ID: 36740774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in antithyroid drug treatment of Graves' disease.
    Okosieme OE; Lazarus JH
    Expert Opin Pharmacother; 2016 Oct; 17(15):2005-17. PubMed ID: 27615550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial.
    Wisnu W; Alwi I; Nafrialdi N; Harimurti K; Pemayun TGD; Jusman SWA; Santoso DIS; Harahap AR; Suwarto S; Subekti I
    Front Endocrinol (Lausanne); 2021; 12():796194. PubMed ID: 34987480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the pharmacological management of hyperthyroidism due to Graves' disease.
    Bartalena L; Tanda ML; Bogazzi F; Piantanida E; Lai A; Martino E
    Expert Opin Pharmacother; 2005 Jun; 6(6):851-61. PubMed ID: 15952916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission following antithyroid drug withdrawal in patients with Graves' hyperthyroidism: parameters with prognostic value.
    García-Mayor RV; Álvarez-Vázquez P; Fluiters E; Valverde D; Andrade A
    Endocrine; 2019 Feb; 63(2):316-322. PubMed ID: 30334140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
    Kallner G; Vitols S; Ljunggren JG
    J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.
    Emiliano AB; Governale L; Parks M; Cooper DS
    J Clin Endocrinol Metab; 2010 May; 95(5):2227-33. PubMed ID: 20335447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
    van Soestbergen MJ; van der Vijver JC; Graafland AD
    J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
    Okamura K; Sato K; Fujikawa M; Bandai S; Ikenoue H; Kitazono T
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3995-4002. PubMed ID: 25144628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
    Chattaway JM; Klepser TB
    Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
    Tonacchera M; Chiovato L; Bartalena L; Cavaliere AF; Vitti P
    J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of hyperthyroidism: state of the art.
    Fumarola A; Di Fiore A; Dainelli M; Grani G; Calvanese A
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):678-84. PubMed ID: 20496313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of hyperthyroidism.
    Hartzband PI; Solomon DH
    Dis Mon; 1981 Jul; 27(10):1-74. PubMed ID: 6168458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.